|
|
| | capuramycin Basic information |
| Product Name: | capuramycin | | Synonyms: | capuramycin;1-[5-O-[4,6-Dideoxy-6-oxo-6-[[[(3S)-hexahydro-2-oxo-1H-azepine]-3-yl]amino]-β-L-erythro-4-hexenopyranosyl]-3-O-methyl 6-deoxy-6-amino-α-L-talofuranuronosyl]-1,2,3,4-tetrahydro-2,4-dioxopyrimidine;A-500359B;Antibiotic 446S3-1;α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- | | CAS: | 102770-00-3 | | MF: | C23H31N5O12 | | MW: | 569.52 | | EINECS: | | | Product Categories: | | | Mol File: | 102770-00-3.mol |  |
| | capuramycin Chemical Properties |
| density | 1.60±0.1 g/cm3(Predicted) | | pka | 9.39±0.10(Predicted) |
| | capuramycin Usage And Synthesis |
| | capuramycin Preparation Products And Raw materials |
|